Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia

Am J Hematol. 2011 Sep;86(9):785-7. doi: 10.1002/ajh.22081. Epub 2011 Jul 28.
No abstract available

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Resistance*
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Male
  • Medical Records
  • Neuralgia / chemically induced
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / physiopathology
  • Purpura, Thrombocytopenic, Idiopathic / prevention & control
  • Remission Induction
  • Retrospective Studies
  • Secondary Prevention
  • Tubulin Modulators / administration & dosage
  • Tubulin Modulators / adverse effects
  • Tubulin Modulators / therapeutic use*
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects
  • Vinblastine / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Tubulin Modulators
  • Vinblastine